Skip to content
Browse
LatestWorldBusinessSci & TechEntertainmentSportsHealthGames

Edition

GLGlobalUSUSACACanadaUKUKINIndiaPKPakistanSGSingaporeAUAustralia

Sections

Appearance

AboutSourcesContactPrivacy

Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue

The strong performance the company has delivered in Q2 reflected the strength of the business fundamentals, sustained execution and the resilience of its diversified product portfolio.

First reported by The Hindu 1 source
Image: The Hindu
Image: The Hindu
Read at The Hindu(opens in a new tab)

Full coverage

Every report we found on this story, oldest first. Each links to the original publisher.

  1. The Hindu

    Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue (opens The Hindu in a new tab)

    The strong performance the company has delivered in Q2 reflected the strength of the business fundamentals, sustained execution and the resilience of its diversified product portfolio.

Something wrong with how we've grouped or summarised this story? Report a problem

More in Business

More